Teradata Corp
TDC
29.16
-0.46
-1.55%
Teradata Corp
US · TDC
#2565 by market cap
Listed 1970
29.16
-0.46
-1.55%
Live - 5344 symbols - heartbeat 36s ago
· 2026-10-08 04:00
Pre-market
29.06
-0.35%
After-hours
29.16
0.00%
Overnight
29.16
0.00%
- Market cap
- 2.71B
- P/E (TTM)i
- 6.14
- P/Bi
- 4.57
- EPSi
- 1.35
- Div yieldi
- 0.00%
- 52W posi
- 41%
Reader sentiment
Are you bullish or bearish on TDC?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 0.80, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -4.97% YoY
Margins
- Gross margin
- 59.35%
- Operating margin
- 12.33%
- Net margin
- 7.82%
Key ratios & quality
- Enterprise valuei
- 2.73B
- PEG ratioi
- 0.11
- Altman Z-Scorei
- 0.80
PEG uses trailing P/E against the 3-year net income growth rate (57.93%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.16B | 1.90B | 1.84B | 1.92B | 1.80B | 1.83B | 1.75B | 1.66B |
| Gross profit | 1.03B | 955.00M | 1.02B | 1.19B | 1.08B | 1.12B | 1.06B | 987.00M |
| Selling & admin expenses | 666.00M | 618.00M | 669.00M | 646.00M | 650.00M | 635.00M | 565.00M | 502.00M |
| Research & development | 317.00M | 327.00M | 334.00M | 309.00M | 313.00M | 294.00M | 284.00M | 280.00M |
| Operating profit | 43.00M | 10.00M | 16.00M | 231.00M | 118.00M | 186.00M | 209.00M | 205.00M |
| Pretax profit | 27.00M | -13.00M | -24.00M | 192.00M | 67.00M | 117.00M | 164.00M | 178.00M |
| Tax | -3.00M | 7.00M | -153.00M | 45.00M | 34.00M | 55.00M | 50.00M | 48.00M |
| Net profit | 30.00M | -20.00M | 129.00M | 147.00M | 33.00M | 62.00M | 114.00M | 130.00M |
| Basic EPS | 0 | 0 | 1 | 1 | 0 | 1 | 1 | 1 |
| Diluted EPS | 0.25 | -0.18 | 1.16 | 1.30 | 0.31 | 0.61 | 1.16 | 1.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 418.00M | 408.00M | 416.00M | 421.00M | 444.00M | 410.00M |
| Gross profit | 248.00M | 230.00M | 253.00M | 256.00M | 276.00M | 243.00M |
| Selling & admin expenses | 116.00M | 135.00M | 122.00M | 129.00M | 240.00M | 120.00M |
| Research & development | 66.00M | 71.00M | 70.00M | 73.00M | 72.00M | 75.00M |
| Operating profit | 66.00M | 24.00M | 61.00M | 54.00M | -36.00M | 48.00M |
| Pretax profit | 58.00M | 13.00M | 54.00M | 53.00M | 437.00M | 47.00M |
| Tax | 14.00M | 4.00M | 14.00M | 16.00M | 102.00M | 1.00M |
| Net profit | 44.00M | 9.00M | 40.00M | 37.00M | 335.00M | 46.00M |
| Basic EPS | 0 | 0 | 0 | 0 | 4 | 0 |
| Diluted EPS | 0.45 | 0.09 | 0.42 | 0.38 | 3.47 | 0.48 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.43B | 1.01B | 1.04B | 1.11B | 1.03B | 869.00M | 749.00M | 837.00M |
| Cash & ST investments | 715.00M | 494.00M | 529.00M | 592.00M | 569.00M | 486.00M | 420.00M | 493.00M |
| Inventory | 28.00M | 31.00M | 29.00M | 26.00M | 8.00M | 13.00M | 18.00M | 13.00M |
| Total assets | 2.36B | 2.06B | 2.19B | 2.17B | 2.02B | 1.87B | 1.70B | 1.78B |
| Total current liabilities | 1.01B | 886.00M | 952.00M | 1.03B | 1.01B | 996.00M | 930.00M | 914.00M |
| Short-term debt | 36.00M | 100.00M | 134.00M | 177.00M | 75.00M | 91.00M | 86.00M | 77.00M |
| Long-term debt | 478.00M | 454.00M | 411.00M | 324.00M | 498.00M | 480.00M | 455.00M | 431.00M |
| Total liabilities | 1,865,000,000.00 | 1,795,000,000.00 | 1,793,000,000.00 | 1,709,000,000.00 | 1,764,000,000.00 | 1,738,000,000.00 | 1,571,000,000.00 | 1,549,000,000.00 |
| Total equity | 495.00M | 262.00M | 400.00M | 460.00M | 258.00M | 135.00M | 133.00M | 230.00M |
| Retained earnings | -823.00M | -1.14B | -1.11B | -1.21B | -1.57B | -1.81B | -1.91B | -1.92B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 791.00M | 757.00M | 811.00M | 837.00M | 1.24B | 773.00M |
| Cash & ST investments | 368.00M | 369.00M | 406.00M | 493.00M | 816.00M | 414.00M |
| Inventory | 13.00M | 5.00M | 5.00M | 13.00M | 5.00M | 5.00M |
| Total assets | 1.75B | 1.74B | 1.76B | 1.78B | 2.14B | 1.66B |
| Total current liabilities | 946.00M | 898.00M | 906.00M | 914.00M | 954.00M | 845.00M |
| Short-term debt | 91.00M | 89.00M | 84.00M | 77.00M | 76.00M | 48.00M |
| Long-term debt | 449.00M | 443.00M | 437.00M | 431.00M | 424.00M | -- |
| Total liabilities | 1,594,000,000.00 | 1,561,000,000.00 | 1,542,000,000.00 | 1,549,000,000.00 | 1,585,000,000.00 | 1,065,000,000.00 |
| Total equity | 158.00M | 176.00M | 219.00M | 230.00M | 557.00M | 593.00M |
| Retained earnings | -1.91B | -1.93B | -1.92B | -1.92B | -1.62B | -1.62B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 364.00M | 148.00M | 267.00M | 463.00M | 419.00M | 375.00M | 303.00M | 305.00M |
| Depreciation & amortization | 130.00M | 150.00M | 172.00M | 149.00M | 134.00M | 116.00M | 100.00M | 90.00M |
| Free cash flow | 204.00M | 89.00M | 216.00M | 432.00M | 403.00M | 355.00M | 277.00M | 285.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -300.00M | -300.00M | -100.00M | -244.00M | -387.00M | -308.00M | -215.00M | -140.00M |
| Ending cash balance | 716.00M | 496.00M | 533.00M | 595.00M | 571.00M | 486.00M | 421.00M | 494.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 8.00M | 43.00M | 94.00M | 160.00M | 401.00M | 106.00M |
| Depreciation & amortization | 20.00M | 23.00M | 24.00M | 23.00M | 25.00M | 23.00M |
| Free cash flow | 7.00M | 39.00M | 88.00M | 151.00M | 390.00M | 105.00M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -44.00M | -28.00M | -30.00M | -38.00M | -34.00M | -40.00M |
| Ending cash balance | 369.00M | 370.00M | 407.00M | 494.00M | 816.00M | 415.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 5.16 | -5.28 | 38.97 | 34.19 | 9.19 | 31.55 | 85.07 | 71.63 |
| ROA %i | 1.22 | -0.91 | 6.07 | 6.74 | 1.57 | 3.18 | 6.37 | 7.46 |
| ROIC %i | 2.88 | -0.99 | 14.79 | 15.65 | 4.16 | 7.90 | 17.05 | 19.04 |
| 5-year avg ROE %i | 2.91 | -2.26 | 8.88 | 12.97 | 16.45 | 21.72 | 39.80 | 46.33 |
| EBIT margin %i | 2.26 | 0.68 | 0.16 | 11.37 | 5.07 | 8.02 | 11.03 | 12.27 |
| FCF / sales %i | 9.43 | 4.69 | 11.76 | 22.54 | 22.45 | 19.37 | 15.83 | 17.14 |
| Current ratioi | 1.42 | 1.14 | 1.10 | 1.07 | 1.02 | 0.87 | 0.81 | 0.92 |
| Quick ratioi | 1.29 | 1.02 | 0.98 | 0.98 | 0.94 | 0.79 | 0.72 | 0.83 |
| Debt / assetsi | 23.05 | 32.43 | 29.32 | 26.37 | 31.50 | 34.17 | 33.80 | 31.31 |
| LT debt / equityi | 102.63 | 216.41 | 127.25 | 85.87 | 217.83 | 406.67 | 368.42 | 208.70 |
| Interest coveragei | 2.23 | 0.50 | 0.11 | 8.38 | 3.79 | 4.90 | 6.66 | 7.85 |
| Revenue CAGR (3Y) %i | -5.08 | -6.48 | -5.21 | -3.96 | -1.86 | -0.05 | -2.99 | -2.51 |
| Net income CAGR (3Y) %i | -- | -- | -- | 69.85 | -- | -21.67 | -8.13 | 57.93 |
| FCF CAGR (3Y) %i | -10.12 | -35.26 | -3.05 | 28.42 | 65.44 | 18.01 | -13.77 | -10.91 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 130.19 | 87.65 | 68.60 | 71.63 | 117.76 | 119.12 |
| ROA %i | 7.89 | 6.55 | 6.90 | 7.46 | 21.62 | 26.98 |
| ROIC %i | 21.14 | 16.99 | 17.44 | 19.04 | 46.67 | 64.30 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.80 | 10.45 | 11.02 | 12.27 | 34.46 | 36.43 |
| FCF / sales %i | 15.44 | 15.70 | 17.08 | 17.14 | 39.55 | 43.41 |
| Current ratioi | 0.84 | 0.84 | 0.90 | 0.92 | 1.30 | 0.91 |
| Quick ratioi | 0.71 | 0.74 | 0.79 | 0.83 | 1.19 | 0.79 |
| Debt / assetsi | 33.56 | 33.56 | 32.54 | 31.31 | 25.82 | 5.97 |
| LT debt / equityi | 314.56 | 280.68 | 223.29 | 208.70 | 85.64 | 8.60 |
| Interest coveragei | 7.79 | 6.48 | 6.74 | 7.85 | 23.28 | 24.64 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Product sales is the largest reported line at 90.49% of revenue, across 2 reported segments.
- The next-largest line, Consulting services, is a distant second at 9.51% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Product sales90.49%
Consulting services9.51%
Quote time 2026-10-08 04:00:02 · For reference only, not investment advice and not tailored to your situation.